1. Home
  2. BIO vs KBR Comparison

BIO vs KBR Comparison

Compare BIO & KBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIO
  • KBR
  • Stock Information
  • Founded
  • BIO 1952
  • KBR 1901
  • Country
  • BIO United States
  • KBR United States
  • Employees
  • BIO N/A
  • KBR N/A
  • Industry
  • BIO Biotechnology: Laboratory Analytical Instruments
  • KBR Military/Government/Technical
  • Sector
  • BIO Industrials
  • KBR Industrials
  • Exchange
  • BIO Nasdaq
  • KBR Nasdaq
  • Market Cap
  • BIO 8.7B
  • KBR 8.3B
  • IPO Year
  • BIO N/A
  • KBR 2006
  • Fundamental
  • Price
  • BIO $320.44
  • KBR $62.12
  • Analyst Decision
  • BIO Buy
  • KBR Strong Buy
  • Analyst Count
  • BIO 4
  • KBR 9
  • Target Price
  • BIO $369.00
  • KBR $76.00
  • AVG Volume (30 Days)
  • BIO 218.2K
  • KBR 777.5K
  • Earning Date
  • BIO 10-24-2024
  • KBR 10-31-2024
  • Dividend Yield
  • BIO N/A
  • KBR 0.97%
  • EPS Growth
  • BIO N/A
  • KBR N/A
  • EPS
  • BIO N/A
  • KBR 1.48
  • Revenue
  • BIO $2,562,604,000.00
  • KBR $7,173,000,000.00
  • Revenue This Year
  • BIO N/A
  • KBR $9.66
  • Revenue Next Year
  • BIO $4.49
  • KBR $13.63
  • P/E Ratio
  • BIO N/A
  • KBR $41.22
  • Revenue Growth
  • BIO N/A
  • KBR 7.22
  • 52 Week Low
  • BIO $261.59
  • KBR $49.37
  • 52 Week High
  • BIO $384.37
  • KBR $69.50
  • Technical
  • Relative Strength Index (RSI)
  • BIO 50.24
  • KBR 35.63
  • Support Level
  • BIO $311.04
  • KBR $59.67
  • Resistance Level
  • BIO $337.50
  • KBR $67.50
  • Average True Range (ATR)
  • BIO 8.18
  • KBR 1.39
  • MACD
  • BIO -1.35
  • KBR -0.69
  • Stochastic Oscillator
  • BIO 43.70
  • KBR 22.99

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (56% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (44% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (42% of 2023 sales), Europe (31%), Asia (31%), and other (6%). Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

About KBR KBR Inc.

KBR (formerly Kellogg, Brown & Root) is global provider of technology, integrated engineering, procurement, and construction delivery, and operations and maintenance services. The company's business is organized into two segments: government solutions and sustainable technology solutions. KBR has operations in over 30 countries, and employs approximately 34,000 people. The firm generated $7 billion in revenue in 2023.

Share on Social Networks: